H19 and neoplasm: Our data showing that H19 overexpression suppresses 4E-BP1 phosphorylation is consistent with recent clinical findings that high 4E-BP1 phosphorylation levels are associated with poor prognosis in several tumour types, including breast, ovary and prostate tumours39.